Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

Clinical trial NCT02526017 · COMPLETED

Trial details

NCT number: NCT02526017
Sponsor: Five Prime Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Head and Neck Cancer Pancreatic Cancer Ovarian Cancer Renal Cell Carcinoma Malignant Glioma Non-small Cell Lung Cancer

Start date: 2015-09-08
Primary completion: 2019-11-18
Enrollment: 313

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.